Cargando…
Correlation between overall survival and differential plasma and tissue tumor marker expression in nasopharyngeal carcinoma patients with different sites of organ metastasis
Differential overall survival of nasopharyngeal carcinoma (NPC) with different organ site metastases has been documented. Here, we attempted to determine the underlying mechanisms by assessing plasma and tumor tissue markers in relation to patient survival. Pretreatment plasma Epstein-Barr virus (EB...
Autores principales: | Wang, Hung-Ming, Lin, Tung-Liang, Kuo, Yung-Chia, Li, Hsin-Pai, Chang, Kai-Ping, Lin, Chien-Yu, Fan, Hsien-Chi, Lin, An-Chi, Hsieh, Chia-Hsun, Tsang, Ngan-Ming, Lee, Li-Yu, Chan, Sheng-Chieh, Lui, Kar-Wai, Chang, Yu-Sun, Hsu, Cheng-Lung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288180/ https://www.ncbi.nlm.nih.gov/pubmed/27448966 http://dx.doi.org/10.18632/oncotarget.10676 |
Ejemplares similares
-
Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma
por: Hsu, Cheng-Lung, et al.
Publicado: (2015) -
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
por: Hsu, Cheng-Lung, et al.
Publicado: (2018) -
Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment
por: Li, Hsin-Pai, et al.
Publicado: (2021) -
Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways
por: Li, Hsin-Pai, et al.
Publicado: (2023) -
Progesterone analogues reduce plasma Epstein–Barr virus DNA load and improve pain control in recurrent/metastatic nasopharyngeal carcinoma patients under supportive care
por: Hung, Chia-Yen, et al.
Publicado: (2017)